Franklin Resources Inc. boosted its stake in shares of Humana Inc. (NYSE:HUM – Free Report) by 914.5% in the 4th quarter, HoldingsChannel.com reports. The fund owned 1,255,665 shares of the insurance provider’s stock after purchasing an additional 1,131,893 shares during the quarter. Franklin Resources Inc.’s holdings in Humana were worth $321,613,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds also recently made changes to their positions in the company. Capital International Investors grew its holdings in shares of Humana by 113.9% in the 4th quarter. Capital International Investors now owns 5,818,008 shares of the insurance provider’s stock worth $1,490,239,000 after purchasing an additional 3,097,571 shares during the last quarter. Norges Bank bought a new position in Humana during the 4th quarter valued at about $456,632,000. Massachusetts Financial Services Co. MA boosted its position in Humana by 28.9% in the fourth quarter. Massachusetts Financial Services Co. MA now owns 4,496,775 shares of the insurance provider’s stock valued at $1,151,759,000 after buying an additional 1,008,514 shares in the last quarter. Neuberger Berman Group LLC boosted its position in Humana by 2,855.5% in the third quarter. Neuberger Berman Group LLC now owns 530,775 shares of the insurance provider’s stock valued at $138,092,000 after buying an additional 512,816 shares in the last quarter. Finally, 8 Knots Management LLC grew its stake in Humana by 671.0% during the second quarter. 8 Knots Management LLC now owns 441,623 shares of the insurance provider’s stock worth $107,968,000 after buying an additional 384,345 shares during the last quarter. Institutional investors and hedge funds own 92.38% of the company’s stock.
Wall Street Analysts Forecast Growth
A number of research analysts have recently issued reports on the stock. Leerink Partners lifted their target price on shares of Humana from $185.00 to $255.00 and gave the company a “market perform” rating in a research note on Thursday, April 30th. Raymond James Financial restated an “outperform” rating and set a $260.00 price target on shares of Humana in a research report on Friday, May 1st. Oppenheimer raised Humana from an “outperform” rating to an “outperform” rating in a report on Wednesday, May 20th. JPMorgan Chase & Co. boosted their price objective on Humana from $214.00 to $316.00 and gave the stock a “neutral” rating in a research note on Monday. Finally, Piper Sandler reaffirmed a “neutral” rating and issued a $254.00 price target (up from $182.00) on shares of Humana in a report on Wednesday, May 13th. One research analyst has rated the stock with a Strong Buy rating, nine have issued a Buy rating, fourteen have given a Hold rating and four have assigned a Sell rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and an average price target of $286.13.
Humana Stock Performance
Shares of HUM stock opened at $355.48 on Tuesday. The stock has a market cap of $42.68 billion, a PE ratio of 38.02, a price-to-earnings-growth ratio of 2.00 and a beta of 0.76. The stock has a 50-day moving average of $252.05 and a 200-day moving average of $233.24. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.77 and a quick ratio of 1.77. Humana Inc. has a one year low of $163.11 and a one year high of $356.01.
Humana (NYSE:HUM – Get Free Report) last posted its earnings results on Wednesday, April 29th. The insurance provider reported $10.31 earnings per share for the quarter, topping the consensus estimate of $9.97 by $0.34. The company had revenue of $39.65 billion for the quarter, compared to analyst estimates of $39.37 billion. Humana had a net margin of 0.82% and a return on equity of 10.45%. The business’s revenue for the quarter was up 23.5% compared to the same quarter last year. During the same period last year, the business posted $11.58 earnings per share. Humana has set its FY 2026 guidance at 9.000- EPS. As a group, sell-side analysts expect that Humana Inc. will post 9 earnings per share for the current year.
Humana Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Friday, June 26th will be issued a dividend of $0.885 per share. The ex-dividend date is Friday, June 26th. This represents a $3.54 annualized dividend and a yield of 1.0%. Humana’s payout ratio is currently 37.86%.
About Humana
Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.
In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.
Featured Articles
- Five stocks we like better than Humana
- 3 Stocks With Fresh Catalysts to Watch Before the July 4
- Amprius Insiders Are Selling: Should Investors Be Worried?
- A Weaker Dollar Could Put These 3 Industrial Stocks Back in Focus
- A Market Rotation Toward Quality Will Benefit These 3 ETFs
Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM – Free Report).
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.
